ORLANDO, Fla. ā€”A South Florida boy has survived a rare brain-eating amoeba that kills most people, aided in part because a hard-to-get drug to fight the infection is made by a company based in Orlando where he was hospitalized, doctors said Tuesday.

Sebastian DeLeon came to the hospital two weeks ago with sensitivity to light and a headache so severe the 16-year-old couldnā€™t tolerate anyone touching him, doctors at Florida Hospital for Children said at a news conference.

Hospital staffers had been trained to look for the amoeba, which often is contracted through the nose when swimming in freshwater lakes or rivers. The infection has a fatality rate of 97 percent and another boy died from it at the same hospital two years ago.

The Centers for Disease Control and Prevention says only four out of 138 people have survived being infected with the amoeba in the past 50 years, including DeLeon, according to the hospitalā€™s doctors.

ā€œIt is so rare that a lot of times we donā€™t think of it and thatā€™s where a delay occurs in starting a treatment,ā€ said Dr. Dennis Hernandez, head of the hospitalā€™s emergency department. ā€œIt wasnā€™t very clear-cut and Iā€™m still shaking about the whole case.ā€

DeLeon, who had worked as a camp counselor in Broward County, was infected in South Florida. He began having a severe headache two weeks ago on the same day his family traveled to Orlando for a vacation. His parents took him to the emergency room at Florida Hospital almost a day and a half later when his headache worsened.

Advertisement

Acting on a hunch, emergency room doctors ordered a spinal tap to test for meningitis, and lab scientist Sheila Black found the amoeba moving in the spinal fluid. Doctors lowered the teenā€™s body temperature to 33 degrees, induced a coma, inserted a breathing tube and gave him a cocktail of drugs that help kill the amoeba.

One of the drugs, miltefosine, isnā€™t readily available at most hospitals.

ā€œWhen the family came to me, I had to tell them to say their goodbyes,ā€ said Dr. Humberto Liriano, who choked up as he described the case. ā€œI had to tell them, ā€˜Tell him everything you would want to tell your child because I donā€™t know if he will wake up.ā€™ ā€

Luck was on DeLeonā€™s side since the manufacturer of miltefosine is based in Orlando, and a shipment got to the hospital quickly.

ā€œThis infection can be rapidly fatal. Minutes count and having the drug rapidly at hand ā€¦ is crucial,ā€ said Dr. Federico Laham, a hospital pediatrician specializing in infectious diseases.

Because the amoeba infection is so rare, the Centers for Disease Control and Prevention typically flies the drug miltefosine to the patient. But in DeLeonā€™s case, a hospital pharmacist called the chief executive of Profounda Inc., the Orlando-based company that manufactures the drug and the CEOā€™s son dropped it off at the hospital within minutes.

DeLeon is expected to recover with therapy. He is still at the hospital and needs a walker to get around, doctors said.


Only subscribers are eligible to post comments. Please subscribe or login first for digital access. Hereā€™s why.

Use the form below to reset your password. When you've submitted your account email, we will send an email with a reset code.